Literature DB >> 21822888

Gene targeting in human pluripotent stem cells.

Ying Liu1, Mahendra Rao.   

Abstract

Targeted homologous recombination (HR) is an essential tool in stem cell biology. It can be used to study gene function and is a highly developed technology in the mouse where precise genetic modifications are introduced into the genome via HR in mouse embryonic stem cells (mESCs). However, gene targeting has not been widely applied to the study of human pluripotent stem cells (hPSCs) due to its relatively low efficiency in human cell lines. To overcome this technical hurdle, we have developed and established a protocol that allows efficient gene targeting in hPSC lines. This chapter provides a detailed protocol for efficiently performing gene targeting in hPSCs by electroporation. The protocol describes methods for cell preparation, antibiotic selection, and excision of the selectable marker following gene targeting. While we can only target one allele at a time, HR covers a broad range of important applications including making knock-in reporter lines and knock-in lineage tracers, generating disease models that are caused by dominant mutants, repair of patient-derived induced PSCs that only involve a single allele mutation, and knocking out genes that are located on the X chromosome in male lines. When targeting to both alleles is needed, such as generation of a knockout cell line, the cells can be electroporated twice with targeting vectors designed to target each of the alleles. This protocol will find broad applications in generating lineage-specific reporter lines and point mutations in genetic repair in disease models using hPSCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822888     DOI: 10.1007/978-1-61779-201-4_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.

Authors:  Florian T Merkle; Werner M Neuhausser; David Santos; Eivind Valen; James A Gagnon; Kristi Maas; Jackson Sandoe; Alexander F Schier; Kevin Eggan
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

Review 2.  Concise review: modeling central nervous system diseases using induced pluripotent stem cells.

Authors:  Xianmin Zeng; Joshua G Hunsberger; Anton Simeonov; Nasir Malik; Ying Pei; Mahendra Rao
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

3.  Efficient p53 gene targeting by homologous recombination in rat-induced pluripotent stem cells.

Authors:  G Li; Y Chunxu; L Guisheng
Journal:  Cell Prolif       Date:  2012-12-21       Impact factor: 6.831

Review 4.  Recent advances in the development of new transgenic animal technology.

Authors:  Xiangyang Miao
Journal:  Cell Mol Life Sci       Date:  2012-07-26       Impact factor: 9.261

5.  Direct cloning of isogenic murine DNA in yeast and relevance of isogenicity for targeting in embryonic stem cells.

Authors:  Claes Andréasson; Anna J Schick; Susanne M Pfeiffer; Mihail Sarov; Francis Stewart; Wolfgang Wurst; Joel A Schick
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

6.  User-Friendly Genetic Conditional Knockout Strategies by CRISPR/Cas9.

Authors:  Liangliang Chen; Ying Ye; Hongxia Dai; Heyao Zhang; Xue Zhang; Qiang Wu; Zhexin Zhu; Rapolas Spalinskas; Wenyan Ren; Wensheng Zhang
Journal:  Stem Cells Int       Date:  2018-06-14       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.